BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 31568814)

  • 1. Exploiting epigenetic vulnerabilities in solid tumors: Novel therapeutic opportunities in the treatment of SWI/SNF-defective cancers.
    Chabanon RM; Morel D; Postel-Vinay S
    Semin Cancer Biol; 2020 Apr; 61():180-198. PubMed ID: 31568814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploiting vulnerabilities of SWI/SNF chromatin remodelling complexes for cancer therapy.
    Wanior M; Krämer A; Knapp S; Joerger AC
    Oncogene; 2021 May; 40(21):3637-3654. PubMed ID: 33941852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mammalian SWI/SNF Chromatin Remodeling Complexes: Emerging Mechanisms and Therapeutic Strategies.
    Centore RC; Sandoval GJ; Soares LMM; Kadoch C; Chan HM
    Trends Genet; 2020 Dec; 36(12):936-950. PubMed ID: 32873422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammalian SWI/SNF complexes in cancer: emerging therapeutic opportunities.
    St Pierre R; Kadoch C
    Curr Opin Genet Dev; 2017 Feb; 42():56-67. PubMed ID: 28391084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Interaction of SWI/SNF with the Ribosome Regulates Translation and Confers Sensitivity to Translation Pathway Inhibitors in Cancers with Complex Perturbations.
    Ulicna L; Kimmey SC; Weber CM; Allard GM; Wang A; Bui NQ; Bendall SC; Crabtree GR; Bean GR; Van Rechem C
    Cancer Res; 2022 Aug; 82(16):2829-2837. PubMed ID: 35749589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SWI/SNF chromatin remodeling and human malignancies.
    Masliah-Planchon J; Bièche I; Guinebretière JM; Bourdeaut F; Delattre O
    Annu Rev Pathol; 2015; 10():145-71. PubMed ID: 25387058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remodeling the cancer epigenome: mutations in the SWI/SNF complex offer new therapeutic opportunities.
    Orlando KA; Nguyen V; Raab JR; Walhart T; Weissman BE
    Expert Rev Anticancer Ther; 2019 May; 19(5):375-391. PubMed ID: 30986130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruption of mammalian SWI/SNF and polycomb complexes in human sarcomas: mechanisms and therapeutic opportunities.
    McBride MJ; Kadoch C
    J Pathol; 2018 Apr; 244(5):638-649. PubMed ID: 29359803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BAFfling pathologies: Alterations of BAF complexes in cancer.
    Arnaud O; Le Loarer F; Tirode F
    Cancer Lett; 2018 Apr; 419():266-279. PubMed ID: 29374542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting chromatin defects in selected solid tumors based on oncogene addiction, synthetic lethality and epigenetic antagonism.
    Morel D; Almouzni G; Soria JC; Postel-Vinay S
    Ann Oncol; 2017 Feb; 28(2):254-269. PubMed ID: 28426098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic lethal therapy based on targeting the vulnerability of SWI/SNF chromatin remodeling complex-deficient cancers.
    Sasaki M; Ogiwara H
    Cancer Sci; 2020 Mar; 111(3):774-782. PubMed ID: 31955490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy.
    Kadoch C; Hargreaves DC; Hodges C; Elias L; Ho L; Ranish J; Crabtree GR
    Nat Genet; 2013 Jun; 45(6):592-601. PubMed ID: 23644491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular pathways: SWI/SNF (BAF) complexes are frequently mutated in cancer--mechanisms and potential therapeutic insights.
    Wang X; Haswell JR; Roberts CW
    Clin Cancer Res; 2014 Jan; 20(1):21-7. PubMed ID: 24122795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in the role of SWI/SNF complexes in tumours.
    Li Z; Zhao J; Tang Y
    J Cell Mol Med; 2023 Apr; 27(8):1023-1031. PubMed ID: 36883311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SWI/SNF chromatin-remodeling complexes in cardiovascular development and disease.
    Bevilacqua A; Willis MS; Bultman SJ
    Cardiovasc Pathol; 2014; 23(2):85-91. PubMed ID: 24183004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the SWI/SNF chromatin remodeling complex in pancreatic ductal adenocarcinoma.
    Tsuda M; Fukuda A; Kawai M; Araki O; Seno H
    Cancer Sci; 2021 Feb; 112(2):490-497. PubMed ID: 33301642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivating mutations in SWI/SNF chromatin remodeling genes in human cancer.
    Oike T; Ogiwara H; Nakano T; Yokota J; Kohno T
    Jpn J Clin Oncol; 2013 Sep; 43(9):849-55. PubMed ID: 23904343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vulnerabilities of mutant SWI/SNF complexes in cancer.
    Helming KC; Wang X; Roberts CWM
    Cancer Cell; 2014 Sep; 26(3):309-317. PubMed ID: 25203320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modular Organization and Assembly of SWI/SNF Family Chromatin Remodeling Complexes.
    Mashtalir N; D'Avino AR; Michel BC; Luo J; Pan J; Otto JE; Zullow HJ; McKenzie ZM; Kubiak RL; St Pierre R; Valencia AM; Poynter SJ; Cassel SH; Ranish JA; Kadoch C
    Cell; 2018 Nov; 175(5):1272-1288.e20. PubMed ID: 30343899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic regulation by BAF (mSWI/SNF) chromatin remodeling complexes is indispensable for embryonic development.
    Nguyen H; Sokpor G; Pham L; Rosenbusch J; Stoykova A; Staiger JF; Tuoc T
    Cell Cycle; 2016 May; 15(10):1317-24. PubMed ID: 26986003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.